Population Pharmacokinetic and Pharmacodynamic Modeling of Romiplostim Biosimilar GP40141 and Reference Product in Healthy Volunteers to Evaluate Biosimilarity

Documenti analoghi

• Optimization of Romiplostim Biosimilar Efficacy Trial Using In Silico Clinical Trial Approach for Patients With Immune Thrombocytopenia
  di: Aleksandr Petrov, et al.
  Pubblicazione: (2024)
• Clinical Pharmacology of GP40321 (Insulin Glulisine Biosimilar): Pharmacokinetic and Pharmacodynamic Comparability in a Hyperinsulinemic‐Euglycemic Clamp Procedure
  di: Ekaterina Koksharova, et al.
  Pubblicazione: (2024)
• Bioequivalence Study of Velpatasvir/Sofosbuvir Oral Coated Tablets in Healthy Volunteers Under Fasting Conditions
  di: Sergei Noskov, et al.
  Pubblicazione: (2024)
• Multicenter Single‐Blind Randomized Controlled Trial of the Romiplostim Biosimilar
  di: Anait L. Melikyan, et al.
  Pubblicazione: (2025)
• Pharmacokinetics, Receptor Occupancy, and Pharmacodynamics of Obexelimab Following Intravenous Administration in Adult Healthy Volunteers and in Patients With Rheumatoid Arthritis
  di: Xiaodong Wang, et al.
  Pubblicazione: (2025)